Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation

Transplantation
N BuninS Dunn

Abstract

Veno-occlusive disease (VOD) is the third leading cause of mortality after bone marrow transplant. Management consists of supportive care, with restricted fluids and diuretics. Most patients will recover, but approximately 25% may develop severe life threatening VOD with subsequent respiratory compromise and multiorgan failure. Orthotopic liver transplant has been attempted for a few patients with intractable VOD, but this approach is limited by availability of a cadaveric organ. We report a child who underwent a T-depleted unrelated donor bone marrow transplant for severe aplastic anemia as a manifestation of Schwachman-Diamond syndrome who developed severe VOD. She had evidence of engraftment when liver transplant was considered, and had no evidence of major organ dysfunction. The left lateral segment of her mother's liver was transplanted at day +33 following bone marrow transplantation. The child remains well ten months post-BMT and nine months after liver transplant. A related donor liver transplant may be a justifiable approach in a patient with severe VOD post-BMT.

References

Mar 17, 1988·The New England Journal of Medicine·J F BurdickB A Perler
Jan 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G B McDonaldE D Thomas
Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S I BearmanG B McDonald

❮ Previous
Next ❯

Citations

Nov 1, 2002·Current Treatment Options in Gastroenterology·Ira R. Willner
Sep 24, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Il-Deok KimKoichi Tanaka
Aug 16, 2002·British Journal of Haematology·Yigal Dror, Melvin H Freedman
Dec 11, 2002·British Journal of Haematology·Joan CunninghamNorman Pratt
Apr 17, 2002·Seminars in Hematology·O P Smith
Dec 7, 2002·Journal of Pediatric Hematology/oncology·Georgia B Vogelsang, Jignesh Dalal
Mar 10, 2004·International Journal of Hematology·Tetsuo MitsuiKiyoshi Hayasaka
Apr 12, 2012·Haematologica·Jean DonadieuUNKNOWN Associated investigators of the French Severe Chronic Neutropenia Registry*
Aug 20, 2004·QJM : Monthly Journal of the Association of Physicians·G C MacQuillan, D Mutimer
Mar 31, 2009·Hematology/oncology Clinics of North America·Lauri BurroughsAkiko Shimamura
Sep 18, 2010·Pediatric Transplantation·Nancy BuninKim M Olthoff
Apr 15, 2003·Bone Marrow Transplantation·K Y Chiang, H M Lazarus
Mar 13, 2001·Bone Marrow Transplantation·S CesaroC Messina
Aug 31, 2002·Bone Marrow Transplantation·J W HsuR A Brodsky
Jul 28, 2005·Pediatric Blood & Cancer·Yigal Dror

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.